BIOTECH-ROOM2-L Archives

Moderated conference on GMOs in the pipeline, hosted by the FAO Biotechnology Forum in 2012

Biotech-Room2-L@LISTSERV.FAO.ORG

Options: Use Forum View

Use Proportional Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Biotech-Mod2 <[log in to unmask]>
Reply To:
Biotech-Mod2 <[log in to unmask]>
Date:
Tue, 20 Nov 2012 14:17:08 +0100
Content-Type:
text/plain
Parts/Attachments:
text/plain (27 lines)
I am Mertxe de Renobales again.

I thank all contributors for the information provided in this conference regarding Bt Brinjal in India. After reading it carefully, it is my conclusion that the commercialization of this interesting crop was not realized because of non-scientific reasons. I understand that these reasons are beyond the scope of Section 4 of the Background document, so I will not mention them again.

Adding to the list of quality improved GM crops in the pipeline provided by Pascal Tillie (Message 21), and understanding "in the pipeline" as being at least at the field trial phase, I want to mention a multivitamin-containing corn developed by a research group from the (public) University of Lleida (Spain). According to the investigators, it is destined to small farmers from developing countries and it contains up to 169-fold the normal amount of beta-carotene, 6-fold the normal amount of ascorbate, and double the amount of folate. It was created from an authochtonous South African corn. It is an open pollinated variety (not for hybrid production) of modest productivity, but farmers will be able to keep their seed. The researchers have decided to make it freely available to poor farmers. Field trials are now being conducted in Spain (http://gmoinfo.jrc.ec.europa.eu/gmp_report.aspx?CurNot=B/ES/12/38).

Reference: S. Naqvi et al., "Transgenic multivitamin corn through biofortification of endorsperm with three vitamins representing three distinct metabolic pathways". PNAS 106(19), 7762-7767, 2009.

Mertxe de Renobales Scheifler
Biokimika eta Biologia Molekularra / Bioquímica y Biología Molecular
Farmazia Fakultatea / Facultad de Farmacia
Euskal Herriko Unibertsitatea / Universidad del País Vasco
Paseo de la Universidad 7
01006 Vitoria-Gasteiz
Spain 
Tfno: (+34)-945-013097
Fax: (+34)-945-013014
http://www.ehu.es/lactiker  
e-mail: mertxe.derenobales (at) ehu.es

[To contribute to this conference, send your message to [log in to unmask] For further information on this FAO Biotechnology Forum, see http://www.fao.org/biotech/biotech-forum/]

########################################################################

To unsubscribe from the Biotech-Room2-L list, click the following link:
https://listserv.fao.org/cgi-bin/wa?SUBED1=Biotech-Room2-L&A=1

ATOM RSS1 RSS2